Escherichia coli harboring shiga toxin 2 gene variants: Frequency and association with clinical symptoms

Journal of Infectious Diseases

Volumn 185, Issue 1, 2002, Pages 74-84

  Friedrich, Alexander W ^a,e   Bielaszewska, Martina ^a,e   Zhang, Wen Lan ^a,e   Pulz, Matthias ^b   Kuczius, Thorsten ^c,e   Ammon, Andrea ^d   Karch, Helge ^a,e  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Abteilung Mikrobiologie   (Germany)

^c Dr Brill Partner GmbH Institute for Hygiene and Microbiology   (Germany)

^d ROBERT KOCH INSTITUTE   (Germany)

^e UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SHIGA TOXIN; UNCLASSIFIED DRUG; VEROTOXIN 2;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHILD; CLINICAL FEATURE; DIARRHEA; ESCHERICHIA COLI; GENE FREQUENCY; GENOTYPE; GERMANY; HEMOLYTIC UREMIC SYNDROME; HUMAN; INFANT; MAJOR CLINICAL STUDY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SYMPTOM;

ADHESINS, BACTERIAL; CARRIER PROTEINS; DIARRHEA; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; ESCHERICHIA COLI PROTEINS; FECES; GENOTYPE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; O ANTIGENS; SEROTYPING; SHIGA-LIKE TOXIN II; VARIATION (GENETICS);

EID: 0036139657     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/338115     Document Type: Article

References (50)

1. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome
2. Escherichia coli O157:H7: Clinical, diagnostic, and epidemiological aspects of human infection
3. Perspective: The problem of non-O157 Shiga toxin (verocytotoxin)-producing Escherichia coli
4. Epidemiology and diagnosis of Shiga toxin-producing Escherichia coli infections
5. Non-O157:H7 Shiga toxin (verocytotoxin)-producing Escherichia coli strains: Epidemiological significance and microbiological diagnosis
6. Shiga toxin: Biochemistry, genetics, mode of action, and role in pathogenesis
7. - strain E32511
8. Identification of new verocytotoxin type 2 variant B-subunit genes in human and animal Escherichia coli isolates
9. Cloning and sequencing of a Shiga-like toxin type II variant from an Escherichia coli strain responsible for edema disease of swine
10. A new Shiga toxin variant (Stx2f) from Escherichia coli isolated from pigeons
11. Variants of Shiga-like toxin II constitute a major toxin component in Escherichia coli O157 strains from patients with haemolytic uraemic syndrome
12. Genotyping of Shiga-like toxin genes in non-O157 Escherichia coli strains associated with haemolytic uraemic syndrome
13. The common ovine Shiga toxin 2-containing Escherichia coli serotypes and human isolates of the same serotypes possess a Stx2d toxin type
14. Characterization of Shiga toxin type 2 variant B-subunit in Escherichia coli strains from asymptomatic human carriers by PCR-RFLP
15. Escherichia coli strains isolated from pigs with edema disease produce a variant of Shiga-like toxin II
16. Characterization of a Shiga toxin 2e-converting bacteriophage from an Escherichia coli strain of human origin
17. Diarrhoea associated with Escherichia coli producing porcine oedema disease verotoxin
18. Isolation and virulence factors of verocytotoxin-producing Escherichia coli in human stool samples
19. Isolation of Vero cytotoxin-producing Escherichia coli serotypes O9ab:H- and O101:H-carrying VT2 variant gene sequences from a patient with haemolytic uraemic syndrome
20. Molecular cloning and nucleotide sequence of another variant of the Escherichia coli Shiga-like toxin II family
21. Infektionen des Menschen durch enterohämorrhagische Escherichia coli (EHEC) in Deutschland, 1996
22. Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections
23. Association between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans
24. Use of digoxigenin-labelled oligonucleotide DNA probes for VT2 and VT2 human variant genes to differentiate Vero cytotoxin-producing Escherichia coli strains of serogroup O157
25. Isolation of enterohemorrhagic Escherichia coli O157 strains from patients with hemolytic-uremic syndrome by using immunomagnetic separation, DNA-based methods and direct culture
26. Prevalence of attaching and effacing Escherichia coli in stool samples from patients and controls
27. Simultaneous identification of strains of Escherichia coli serotype O157:H7 and their Shiga-like toxin type by mismatch amplification mutation assay-multiplex PCR
28. Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxin
29. Shiga toxin-producing Escherichia coli infections in Germany
30. Construction of recombinant Shiga-like toxin-IIv (SLT-IIv) and its use in monitoring the SLT-IIv antibody status in pigs
31. Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in orally infected mouse model
32. Virulence of Shiga toxin-producing Escherichia coli (STEC) in orally-infected mice correlates with the type of toxin produced by the infecting strain
33. Development of verotoxin 2- and verotoxin 2 variant (VT2v)-specific oligonucleotide probes on the basis of the nucleotide sequence of the B cistron of VT2v from Escherichia coli E32511 and B2F1
34. Clonal relatedness of Shiga-like toxin-producing Escherichia coli O101 strains of human and porcine origin
35. Serological and biochemical properties of Shiga-like toxin (verocytotoxin)-producing strains of Escherichia coli, other than O-group 157, from patients in Germany
36. Molecular detection of sorbitol-fermenting Escherichia coli O157 in patients with hemolytic-uremic syndrome
37. Non-O157 pathogenic Shiga toxin-producing Escherichia coli: Phenotypic and genetic profiling of virulence traits and evidence for clonality
38. Evaluation of a microplate latex agglutination method (verotox-F) for detecting and characterizing verotoxins (Shiga toxins) in Escherichia coli
39. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections
40. Analyzing and interpreting data
41. A genomic island, termed "high pathogenicity island," is present in certain non-O157 Shiga toxin-producing Escherichia coli clonal lineages
42. - strains: Epidemiology, phenotypic and molecular characteristics, and microbiological diagnosis
43. Molecular characterization and epidemiological significance of Shiga toxin-producing Escherichia coli O26 strains
44. Zur verbesserung der gegenwärtigen bakteriologischen diagnostik von enterohämorrhagischen Escherichia coli (EHEC) - Stufenplan für klinische und epidemiologische zwecke
45. Rapid detection and isolation of Shiga-like toxin (verocytotoxin)-producing Escherichia coli by direct testing of individual enterohemolytic colonies from washed sheep blood agar plates in the VTEC-RPLA assay
46. Comparative toxicity and virulence of Escherichia coli clones expressing variant and chimeric Shiga-like toxin type II operons
47. Identification of a clone of Escherichia coli O103:H2 as a potential agent of hemolytic-uremic syndrome in France
48. Polymerase chain reaction amplification, cloning and sequencing of variant Escherichia coli Shiga-like toxin II operons
49. Characterisation of verocytotoxin-producing Escherichia coli isolated from pigs and cattle in northern Italy